Lexington Biosciences Inc. (LXGTF)

[Sabretooth0071]

I also see a lot of valid and intelligent question with no real answers.
I also spent a considerable amount of time reading past events and company news, and would suggest everyone read the Bio's of the present board.
I have read and reread them and am still asking the same questions.
The Board have between them a great deal of experience in many fields and many financial contacts. They appear to be active as paid members on many company Boards. Yet with all that experience at their finger tips they have admitted in the past of having financial problems keeping Lexington on track!

1. It is stated that the Heart Sentry is owned by USC Berkeley and only licensed to Lexington ??

2. Prior to the Heart Sentry being granted a US Patent it as quickly announced that Rosco had left to board and company to pursue other interests ? With 15 years of R&D and so near to the end, just what made him leave?

3. It was also published that one set of tests had been completed, and a second series would be conducted to verify the 1st test results? If the first were as good as published why do a verification ?

4. It was also published that by the end of December 2018 beginning of 2019 the HS would be submitted to the FDA for approval, which not being an invasive procedure would result in a short approval time?

5. It was later published that the FDA submission would be put back until April 2019. ( I have since found out that the approval time will be a minimum of 90 days, making the earliest granted approval to be late June early July 2019).

6.Over the past few month I have sent numerous e mails to MR Willis and as yet I am still waiting for a single response.

It seems the more you dig the more you're left in the dark.

So My guess is it was the Plumber in the bathroom with a pipe wrench !!

Ps : Gopherdat,
I read although listed as O/S the 8 million share were being held in reserve ?